Law, A V <br/><br/>
Cost-effectiveness analyses of the conversion of patients with non-insulin-dependent diabetes mellitus from glipizide to glyburide and of the accompanying pharmacy follow-up clinic.  [electronic resource] 

 -  Clinical therapeutics   
 - 977-87 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0149-2918 
<br/><br/><label>Standard No.: </label>10.1016/0149-2918(95)80076-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Cost-Benefit Analysis<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Drug Costs<br/>Female<br/>Glipizide--economics<br/>Glyburide--economics<br/>Humans<br/>Hypoglycemic Agents--economics<br/>Male<br/>Middle Aged<br/>Retrospective Studies